James Calder
What the fired CDC Director Means for the Pharma Industry
The CDC Director's dismissal may reshape pharma industry priorities, impacting R&D, funding, and regulatory landscapes.
What is the Diabetes Capital of the World?
Discover why India is dubbed the "Diabetes Capital of the World," exploring factors like lifestyle changes and genetic predisposition.
New Frontiers in Insulin Resistance: What Patients and Clinicians Need to Know
Explore new insights in insulin resistance, crucial for patients and clinicians, enhancing understanding and treatment strategies in metabolic health.
AI Search Optimization: The Next Frontier for Pharma Marketing Leaders
Explore how AI search optimization is revolutionizing pharma marketing, enhancing visibility, and driving better patient outcomes.
Pharma Turns to Direct-to-Consumer Telehealth: A Game Changer for GLP-1 Drug Marketing
Discover how telehealth is transforming GLP-1 drug marketing, enhancing patient access and reshaping pharmaceutical strategies for type 2 diabetes and obesity.
Is the Oral GLP-1 Pill Available Yet?
Discover the availability of the oral GLP-1 pill, Rybelsus, a breakthrough in type 2 diabetes treatment offering convenience and accessibility.
What is Most Favored Nation Pricing in Pharma?
Explore Most Favored Nation Pricing in pharma, a model aiming to harmonize drug costs globally by referencing the lowest international prices.